Theralase Technologies Inc (TLTFF)

[Naamplao]

That is the a low priority focus not the primary priority focus.

How can they determine optimum efficacy when they don't even know the dose they chose will be the right one... it is just their best guess based on what they know from rat studies.

Theralase and investors will be excited if there is even a minor show of efficacy and the drug and procedure is found to be safe and the patient tolerates the procedure well. Then they can proceed to the next phase to determine the optimum dose.